ProgenaCare Global is a purpose-driven medical device company based in Marietta, Georgia. They have developed ProgenaMatrix, the first commercially available human keratin matrix for wound care. With their unique keratin technology, ProgenaMatrix offers effective and cost-efficient treatment for patients with complex wounds. Their solutions are designed to fit into healthcare practices across different socioeconomic backgrounds, helping physicians reduce the time required for wound closure in diabetic wounds. Founded in 2008, ProgenaCare Global is focused on leveraging cutting-edge advances in biomaterials to improve the healing of chronic wounds.